Literature DB >> 10860866

Contribution of the plasmin/matrix metalloproteinase cascade to the retraction of human fibroblast populated collagen lattices.

A Berton1, S Lorimier, H Emonard, D Laurent-Maquin, W Hornebeck, G Bellon.   

Abstract

To assess the contribution of the plasmin/matrix metalloproteinase cascade in lattices retraction, human gingival fibroblast-populated collagen lattices were supplemented with plasminogen. The rate of lattice retraction was enhanced by addition of plasminogen. This effect was concomitant to plasmin generation, prostromelysin-1 and procollagenase activation. Plasminogen-mediated initiation of that proteolytic cascade was accompanied by conspicuous changes in cell morphology and collagen fibers organization. At day 1 of culture fibroblasts shifted from a rounded (control) to an elongated (in presence of plgn) shape. At the latest stage of retraction, intense vacuolization around fibroblasts was noticed in plgn-supplemented lattices which paralleled the increased collagen degradation. Plgn-enhancing influence on the initial phase of lattice retraction could be totally annihilated by either aprotinin or Batimastat. Those data emphasize the crucial importance of the plasmin-MMP proteolytic cascade in granulation tissue retraction in a healing wound. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860866     DOI: 10.1006/mcbr.2000.0210

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  2 in total

1.  Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin.

Authors:  John Orchard; Andrew Massey; Richard Brown; Adéline Cardon-Dunbar; Jamie Hofmann
Journal:  Clin Orthop Relat Res       Date:  2008-05-01       Impact factor: 4.176

2.  Nerve growth factor has a modulatory role on human primary fibroblast cultures derived from vernal keratoconjunctivitis-affected conjunctiva.

Authors:  Alessandra Micera; Alessandro Lambiase; Barbara Stampachiacchiere; Roberto Sgrulletta; Eduardo Maria Normando; Sergio Bonini; Stefano Bonini
Journal:  Mol Vis       Date:  2007-06-21       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.